Litcius/Paper detail

PIKfyve: a lipid kinase target for COVID-19, cancer and neurodegenerative disorders

P. J. Huang, Shirit Einav, Christopher R. M. Asquith

2021Nature Reviews Drug Discovery29 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)KinaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineCancer researchBiologyBiochemistryInternal medicineDiseaseInfectious disease (medical specialty)PARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesCancer, Stress, Anesthesia, and Immune Response
PIKfyve: a lipid kinase target for COVID-19, cancer and neurodegenerative disorders | Litcius